Learn More
Bio X Cell Biosimilar Antibody, PD-L1, Atezolizumab Clone, 5 MG
Supplier: Bio X Cell SIM0009R005MG
This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Atezolizumab, making it suitable for research applications. It targets human PD-L1 (programmed death ligand 1), also recognized as B7-H1 or CD274. Atezolizumab works by blocking the interaction of PD-L1 with PD-1 and CD80, which is believed to play a significant role in tumor immune evasion.
- Isotype: Human IgG1
- Mutations: N297A
- Formulation: PBS, pH 7.0, contains no stabilizers or preservatives
- Endotoxin: ≤0.5 EU/mg
- Purity: ≥95% (determined by SDS-PAGE)
- Sterility: 0.2 μm filtration
- Purification: Protein A
- Molecular Weight: 150 kDa
- Storage: Store at 4°C; do not freeze.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.